Notice Number: NOT-RM-17-021

Key Dates
Release Date: May 12, 2017

Estimated Publication Date of Announcement: July 2017
First Estimated Application Due Date: October 2017
Earliest Estimated Award Date: June 2018
Earliest Estimated Start Date: July 2018

Related Announcements
NOT-RM-17-018
NOT-RM-17-019
NOT-RM-17-020
RFA-RM-17-014

Issued by
Office of Strategic Coordination (Common Fund)

Purpose

The NIH Office of Strategic Coordination (Common Fund) intends to address challenges in the generation and use of metabolomic data in order to continue to build the national capacity for metabolomics and support the development of resources that catalyze the effective use of metabolomics in basic and translational biomedical research. Common Fund will publish four distinct but integrated Funding Opportunity Announcements (FOAs) that solicit applications for the second phase of the Common Fund Metabolomics Program.

The FOAs are intended for release in summer 2017 with expected application due dates in fall 2017.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

This FOA will utilize the U2C activity code. Details of the planned FOA are provided below.

Research Initiative Details

The Common Fund Metabolomics Program views community engagement and multi-directional communication as essential to overcome challenges in realizing the potential of metabolomics in biomedical research. The Community Engagement and Program Coordination Center (U2C) will coordinate the required activities of the Common Fund Metabolomics Program Consortium, collaborate with national and international colleagues to identify and develop strategies to address outstanding concerns in the application of metabolomics to biomedical research, such as identification of best practices, reproducibility in data acquisition, and standards for data deposition, and promote use of Consortium resources by the greater biomedical community. Applicants should have experience in organizing multi-faceted consortia and engaging with the greater scientific community, and are expected to be from institutions with a base of ongoing, independently supported, peer-reviewed research projects utilizing metabolomics.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Arthur L. Castle
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-7719
Email: castlea@mail.nih.gov